If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Director/PDMR Shareholding

24 Jun 2008 07:00

RNS Number : 3484X
Imaginatik PLC
24 June 2008
 



Imaginatik Plc (the "Company")

Non-executive Director Letters of Appointment

24 June 2008

Under the terms of the non-executive directors' letter of appointment dated 11 December 2006 in respect of Mr Howard Marshall, Mr Paul Morland and Mr Phil Nutburn (the "Non-Executive Directors"), each Non-Executive Director was paid their fees in new Ordinary shares ("Ordinary Shares") in advance in respect of his initial 12 months of appointment being £30,000, £10,000 (with an additional £15,000 payable in cash to Arbuthnot Securities Limited) and £25,000, respectively.

Under the terms of the same letters of appointment, it was agreed that the Non-Executive Directors would receive new Ordinary shares of 0.0625p in the Company in respect of each subsequent six month period following the end of the initial 12 month term to the value of £15,000 in the case of Mr Marshall, £7,500 in the case of Mr Morland and £12,500 in the case of Mr Nutburn. These Ordinary Shares were to be issued at the average mid market closing price of an Ordinary Share as derived from the London Stock Exchange's Daily Official List for the last five days of such period and within 20 business days of the expiry of the relevant period.

Consequently, at an average price of 4.75p being the average price of an Ordinary Share in Imaginatik over the five dealing days prior to and including 10 June 2008 being 4 June 2008 to 10 June 2008, a total of 736,842 new Ordinary Shares have today been issued. 315,789 Ordinary Shares have been issued to Mr Marshall, 157,895 Ordinary Shares to Mr Morland and 263,158 Ordinary Shares to Mr Nutburn. The shareholdings of the Non-Executive Directors before, and after, this issue of Ordinary Shares are as follows:

Non-Executive Director

Number of Ordinary Shares held prior to Non-Executive share issue 

% of issued share capital

Number of Ordinary Shares held following Non-Executive share issue

% of issued share capital as at 30 June 2008

Howard Marshall

1,358,334

1.09

1,674,123

1.33

Paul Morland

666,668

0.53

824,563

0.66

Phillip Nutburn

333,333

0.27

596,491

0.47

Application for admission of 736,842 new Ordinary Shares ("Admission") has been made and is expected to occur on 30 June 2008. 

Following Admission, the Company will have 125,827,799 Ordinary Shares in issue. 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company. 

Enquiries:

Imaginatik Plc

Shawn Taylor, CFO

0207 917 2975

www.imaginatik.com 

W.H. Ireland

Katy Birkin

0121 265 6330

Investor relations and UK media

ICIS

Tom Moriarty/Caroline Evans-Jones

0207 651 8688

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFJMFTMMATBBP
Date   Source Headline
27th Sep 20187:30 amRNSSuspension - Imaginatik plc
26th Sep 20187:00 amRNSUpdate on potential equity investment
17th Sep 20187:00 amRNSUpdate on potential equity investment
11th Sep 201811:35 amRNSUpdate regarding Nominated Adviser
11th Sep 20187:00 amRNSFinal Results
4th Sep 20187:00 amRNSUpdate on potential equity investment
29th Aug 20189:22 amRNSHolding(s) in Company
28th Aug 20189:12 amRNSHolding(s) in Company
24th Aug 20183:39 pmRNSHolding(s) in Company
17th Aug 20183:40 pmRNSIssue of Equity
26th Jul 20187:00 amRNSNew Finance Agreement
25th Jul 20181:05 pmRNSStmnt re Share Price Movement
10th Jul 20184:56 pmRNSHolding(s) in Company
10th Jul 20189:48 amRNSHolding(s) in Company
10th Jul 20187:00 amRNSAppointment of CEO
3rd Jul 20185:45 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSIssue of Equity
29th Jun 201810:46 amRNSResult of General Meeting and Total Voting Rights
22nd Jun 20187:00 amRNSContract Win
18th Jun 201812:59 pmRNSHolding(s) in Company
15th Jun 20187:00 amRNSRelease of mobile update to Innovation Central
14th Jun 20187:00 amRNSPosting of circular and notice of general meeting
5th Jun 20185:40 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSResult of strategic review and new funding
29th May 20187:00 amRNSUpdate on sales process and funding
1st May 20187:00 amRNSTrading Statement
21st Mar 20187:00 amRNSUpdate on strategic review and formal sale process
14th Feb 201812:38 pmRNSForm 8.3 - [Imaginatik plc]
12th Feb 20185:51 pmRNSForm 8.3 - Imaginatik plc
9th Feb 20185:50 pmRNSForm 8.3 - Imaginatik
9th Feb 20185:48 pmRNSForm 8.3 - Imaginatik
8th Feb 20183:36 pmRNSHolding(s) in Company
1st Feb 20183:04 pmRNSForm 8 (DD) - Imaginatik plc
1st Feb 201811:36 amRNSForm 8.3 - Imaginatik PLC
1st Feb 20187:00 amRNSForm 8 (OPD) - Imaginatik plc
1st Feb 20187:00 amRNSStrategic review including formal sale process
7th Dec 20177:00 amRNSHalf-year Report
29th Sep 20177:00 amRNSGrant of Options
27th Sep 20177:00 amRNSContract Win
20th Sep 20179:37 amRNSHolding(s) in Company
7th Sep 20175:50 pmRNSResult of AGM
15th Aug 20178:00 amRNSNotice of AGM
7th Aug 20177:00 amRNSFinal Results
10th Jul 201710:47 amRNSHolding(s) in Company
5th Jul 20174:32 pmRNSHolding(s) in Company
4th Jul 20179:51 amRNSHolding(s) in Company
4th Jul 20177:00 amRNSHolding(s) in Company
3rd Jul 201711:10 amRNSResult of Open Offer and Total Voting Rights
27th Jun 20177:00 amRNSResult of GM and Total Voting Rights
9th Jun 20171:04 pmRNSPlacing and Open Offer to raise up to £1.9 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.